Phospholipase D is activated and phosphorylated by casein kinase-II in human U87 astroglioma cells

Exp Mol Med. 2006 Feb 28;38(1):55-62. doi: 10.1038/emm.2006.7.

Abstract

Elevated expression of protein casein kinase II (CKII) stimulated basal phospholipase D (PLD) activity as well as PMA-induced PLD activation in human U87 astroglioma cells. Moreover, CKII-selective inhibitor, emodin and apigenin suppressed PMA-induced PLD activation in a dose-dependent manner as well as basal PLD activity, suggesting the involvement of CKII in the activation of both PLD1 and PLD2. CKII was associated with PLD1 and PLD2 in co-transfection experiments. Furthermore, CKII induced serine/threonine phosphorylation of PLD2 in vivo, and the multiple regions of PLD2 were phosphorylated by CKII in vitro kinase assay using glutathione S-transferase-PLD2 fusion protein fragments. Elevated expression of CKII or PLD increased cell proliferation but pretreatment of cells with 1-butanol suppressed CKII-induced cell proliferation. These results suggest that CKII is involved in proliferation of U87 cells at least in part, through stimulation of PLD activity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1-Butanol / pharmacology
  • Astrocytoma / enzymology*
  • Astrocytoma / metabolism
  • Astrocytoma / pathology
  • Blotting, Western
  • Casein Kinase II / analysis
  • Casein Kinase II / pharmacology*
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Dose-Response Relationship, Drug
  • Enzyme Activation
  • Enzyme Inhibitors / pharmacology
  • Glutathione Transferase / metabolism
  • Humans
  • Kinetics
  • Phospholipase D / genetics
  • Phospholipase D / metabolism*
  • Phosphorylation / drug effects
  • Precipitin Tests
  • Recombinant Fusion Proteins / metabolism
  • Tetradecanoylphorbol Acetate / pharmacology

Substances

  • Enzyme Inhibitors
  • Recombinant Fusion Proteins
  • 1-Butanol
  • Glutathione Transferase
  • Casein Kinase II
  • Phospholipase D
  • Tetradecanoylphorbol Acetate